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Dear editor
Further to the recent publication on the “Repeated vertebral augmentation for 
new vertebral compression fractures of postvertebral augmentation patients: a 
 nationwide cohort study”,1 current data highlight the limitations of dual-energy X-ray 
absorptiometry scans. In this context, at best, dual-energy X-ray absorptiometry scans 
(which measure bone mineral density) can account for no greater than 50% of overall 
bone strength (defined as the ability to resist fracture). This is because the resulting 
images are two-dimensional and therefore unable to capture skeletal micro-architecture, 
which also contributes to bone strength.2
A better clinical measure of overall bone strength that more accurately reflects 
the ability of that bone to resist fracture and hence fracture risk reflect an unmet need 
and is urgently required. Recent evidence suggests that micro-computed tomography 
scans, which enable three-dimensional imaging, might provide a solution but use so far 
has necessarily been limited to ex vivo assessment owing to radiation hazards as well 
as technical and accessibility issues.3,4 However micro-computed tomography images 
have identified bone volume fraction (the volumetric distribution of bone mass) as a 
strong determinant of bone strength (r2.0.8).5,6
Further, perhaps other potential tools, alone or in combination with imaging may 
also play a role. For example, serum biomarkers of bone metabolism7,8 along with 
other imaging modalities such as magnetic resonance imaging could capture the 
complex factors that make up bone strength.9 Preexisting algorithms like the FRAX 
(a fracture risk assessment tool calculator)10 might help reduce the overprediction 
issue currently faced.
With regard to the aforementioned evidence, there is a pressing need to consider 
first how we use bone densitometry in the diagnosis of osteoporosis in prostate cancer 
patients, before the National Health Service itself becomes fractured.
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Dear editor
We thank the authors for their interest and comments regarding 
our article.1 The diagnosis of osteoporosis can be made using 
conventional radiography and by measuring the bone mineral 
density (BMD).2 The most popular method of measuring 
BMD is dual-energy X-ray absorptiometry (DEXA) scans. 
DEXA scan is currently recommended by the World Health 
Organization; however, it maybe not a gold standard. The 
accuracy of this density estimate is affected by many factors. 
For example, smaller people with smaller bones will lower the 
scores, machines from different manufacturers use different 
algorithms and yield noncomparable results, and anatomic 
abnormalities, such as previous spine surgery or compression 
fractures, will also skew the measurement. DEXA calculates 
BMD using an area; it is not an accurate measurement of true 
BMD, which is mass divided by a volume. It is unable to rep-
resent the skeletal micro-architecture, which also contributes 
to bone strength.3 In one study, some other technologies such 
as peripheral quantitative computed tomography and micro-
computed tomography were able to improve the ability to 
assess structural parameters of cancellous and cortical bone.4
Recently, some progress has been made in measuring 
biomarkers of bone metabolism. Biomarkers of bone 
metabolism are broadly divided into two categories:5 markers 
of bone resorption, which reflect osteoclast activity and are 
for the most part degradation products of type I collagen; 
markers of bone formation, which reflect osteoblast activity 
and are byproducts of collagen synthesis, matrix proteins, 
or osteoblastic enzymes. These biomarkers can be easily 
measured in serum or urine.
Biomarkers of bone resorption are significantly elevated 
in postmenopausal women with osteoporosis, but the 
biomarkers of bone formation are not elevated and may 
indeed be decreased.6,7 Biomarkers seem to be promising 
for prediction of bone loss, fracture, and response to 
therapy. However, their use alone to predict fracture and for 
osteoporosis diagnosis has yet to be established.8
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